Bone morphogenetic protein and activin membrane-bound inhibitor suppress bone cancer progression in MG63 and SAOS cells via regulation of the TGF-β-induced EMT signaling pathway

Bone cancer is one of the most common tumor types that occurs in bones and their affiliated tissues. The prognosis remains poor due to the limited number of effective therapeutic targets. Downregulation of bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) has been observed in h...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fengsong, Wang, Kai, Zhang, Liang, Yang, Ya-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144885/
https://www.ncbi.nlm.nih.gov/pubmed/30250579
http://dx.doi.org/10.3892/ol.2018.9268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144885/
https://www.ncbi.nlm.nih.gov/pubmed/30250579
http://dx.doi.org/10.3892/ol.2018.9268

Ejemplares similares